ASSIGN Paul Ryan, Clinical Director, North Glasgow CHCP.

Slides:



Advertisements
Similar presentations
Cardiovascular Risk Assessment
Advertisements

Summary Prepared by Melvyn Rubenfire, MD
How would you explain the smoking paradox. Smokers fair better after an infarction in hospital than non-smokers. This apparently disagrees with the view.
Meredith Cook Mercer COPHS August,2012. Total Cholesterol HDL Could CVD prediction be improved by also assessing additional lipid-related markers (replacing.
Lipid Management in 2015: Risk & Controversies
Example: In a heart study the systolic blood pressure was measured for 24 men aged 25 and for 30 men aged 40. Do these data show sufficient evidence to.
Example: In a heart study the systolic blood pressure was measured for 24 men aged 25 and for 30 men aged 40. Do these data show sufficient evidence to.
The FRAX tool for Osteoporosis Should all GP’s be calculating the Frax score prior to treatment Dr Sanjeev Patel Consultant Physician & Senior Lecturer.
Audit on Hypertension in Northwest Russia Архангельск Ingvar Ovhed, MD, PhD, family physician, Competence Center, Blekinge County Council 2008.
CHD Prevention and Risk Asssessment: Old concepts new context? Dr Paul D MacIntyre Director of Cardiology, RHH.
Bridget Dillon February 11,  Cardiovascular disease affects the heart and circulatory system. It is often a result of blockages of blood vessels.
CVD risk estimation and prevention: An overview of SIGN 97.
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
CVD prevention & management: a new approach for primary care Rod Jackson School of Population Health University of Auckland New Zealand.
Absolute cardiovascular disease risk Assessment and Early Intervention Dr Michael Tam Lecturer in Primary Care
COHORH STUDY A research paper on BMJ. What is cohort study? Investigates from exposure to outcome, in a group of patients without, or with appropriate.
Advances and Controversies in Cardiovascular Risk Prediction Peter Brindle General Practitioner R&D lead Bristol, N.Somerset and S.Glouc PCTs Promises,
Inequality and SIMD 2009 West Dunbartonshire. SIMD what is it? Snapshot concentrations of multiple deprivation across Scotland Ranking of 6505 Datazones.
BS704 Class 7 Hypothesis Testing Procedures
Heart Disease Map.
Overly concerning and falsely reassuring?? FRAMINGHAM RISK FACTORS IN THE ED.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
LIFESTYLE MODIFICATIONS FOR PREVENTING HEART DISEASE [e.g. HEART ATTACKS] [ primary prevention of coronary artery disease ] DR S. SAHAI MD [Med.], DM [Card]
Scottish Index of Multiple Deprivation (SIMD) 2009 Inverclyde Council Niamh Laffan Office of the Chief Statistician Scottish Government.
Scottish Index of Multiple Deprivation (SIMD) 2009 East Ayrshire Andrew White Office of the Chief Statistician 16 th February.
The Contribution of Mental Health Services to Tackling Health Inequalities Dr Alastair Cook Chair RCPsych in Scotland.
{ A Novel Tool for Cardiovascular Risk Screening in the Ambulatory Setting Guideline-Based CPRS Dialog Adam Simons MD.
LDL-C target levels (mg/dL)  2 RF:
Results of Monotherapy in ALLHAT: On-treatment Analyses ALLHAT Outcomes for participants who received no step-up drugs.
SIGN CHD In Scotland in the year ending 31 March 2006 over 10,300 patients died from CHD and 5,800 from cerebrovascular disease, with.
RISK FACTOR FOR CORONARY ARTERY DISEASE
William B. Kannel, MD, FACC Former Director, Framingham Heart Study
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial ALLHAT study overview Double-blind, randomized trial to determine whether.
Risk estimation and the prevention of cardiovascular disease SIGN 97.
EXAM 1.A normal adult should have their BP checked at least how often? 2.What level of CVD risk over 10 years is considered high risk for primary prevention?
10 Points to Remember on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsTreatment of Blood Cholesterol to Reduce.
PURE Objective Evaluate the use of cardiovascular drugs for secondary prevention across countries with differing levels of economic development Study Design.
10 Points to Remember on the Assessment of Cardiovascular RiskAssessment of Cardiovascular Risk Summary Prepared by Melvyn Rubenfire, MD.
Standardisation Anthea Springbett. Topics covered in this session Population rates Why do we standardise? How do we standardise? Comparing standardised.
Predicting risk of cardiovascular disease and the cost-effectiveness of interventions in Thailand Stephen Lim On Behalf of the Setting Priorities using.
Keep Well Evidence from the Keep Well programme in NHS Grampian – 2008 to 2014 Jackie Fleming Keep Well Information Analyst.
LOGISTIC REGRESSION A statistical procedure to relate the probability of an event to explanatory variables Used in epidemiology to describe and evaluate.
Scottish Index of Multiple Deprivation (SIMD) 2009 KnowFife Research Fair Niamh Laffan Office of the Chief Statistician Scottish.
Predictive Value of Coronary Calcium Scoring Matthew Budoff, MD, FACC, FAHA Associate Professor of Medicine UCLA School of Medicine Director, Cardiac CT.
Cardiac MCN April 2007 Tackling Health Inequalities: Keep Well Programme.
Section III. Assessment of Overall Cardiovascular Risk in Hypertensive Patients 2015 Canadian Hypertension Education Program Recommendations.
Polypill x Aspirin Project Groups 3 and 4
ALLHAT 6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (3 GROUPS by GFR)
Scottish Index of Multiple Deprivation (SIMD) 2009 Dumfries & Galloway Andrew White Office of the Chief Statistician 05 th February.
6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (4 GROUPS by GFR) ALLHAT.
Scottish Index of Multiple Deprivation (SIMD) 2009 Glasgow City Council Matt Perkins Office of the Chief Statistician 6 th November.
Scottish Index of Multiple Deprivation & Scottish Neighbourhood Statistics Presentation to Big Lottery Fund Andrew White, Euan.
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults Scott W. Rypkema, M.D.
Objectives of Training To provide you with an overview of MSD Informatics Software. To provide you with sufficient training to be able to use MSD Informatics.
Case 1: Elevated LDL-C in a Young Adult. Page 2 of 10 *DALY; disability-adjusted life years Routine checkup:  Age:33 years  Sex: male  Status: Except.
○ South Asians (SAs) have high rates of CHD which are not entirely explained by traditional CVD risk factors. ○ The association of a family history of.
Presented by Slyter Nutrition Consulting Services.
Background/Objective
Physical Health and People with a Severe Mental Illness
Hypertension November 2016
The Anglo Scandinavian Cardiac Outcomes Trial
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Local Tobacco Control Profiles The webinar will start at 1pm
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
ASCORE : An up-to-date cardiovascular risk score for hypertensive patients reflecting. contemporary clinical practices developed. using the ASCOT trial.
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Hypertension November 2016
Section II: Lipid management
Presentation transcript:

ASSIGN Paul Ryan, Clinical Director, North Glasgow CHCP

Risk Scoring Risk scoring Likelihood of having an event in next 10 years Not exact - underestimates for some and over estimates for others In fact most cardiac events occur in lower risk groups

Risk Scoring Original studies (eg Framingham) measured Coronary Heart Risk - CHD Newer studies (JBS 2 and ASSIGN) measure Cardiovascular Risk - CVD CVD Risk is sum of cardiovascular and stroke risk 15% CHD = 20% CVD

Risk Scoring The risk is composite of several risk factors ( age, sex, systolic BP, smoking, cholesterol) and is expressed as probability (% chance) of that person developing event within next ten years Gives threshold for when drug therapy should be instigated but that threshold is assigned arbitrarily since risk is a continuously distributed variable – there is no one point where risk really “takes off”

Risk Scoring For primary prevention i.e. those who have not developed CVD already Aid to Clinical Management Not replace Clinical Judgement May still have to treat individual risk factors in isolation if they are substantial enough (see guidelines) BP consistently >180 and/or 110, familial hypercholesterolemia.

Framingham Based on old studies in USA Does not include family history Does not include deprivation Underreporting in certain socio economic groups Underreporting in older women Measured CHD risk

Risk Scoring Framingham scores significantly under predicted CHD risk in Scottish Male population ( Paisley and Renfrew) Also underestimated risk in lower socio economic groups (Paisley/Renfrew fairly deprived)

JBS 2 Based on Framingham Scores Gives Cardiovascular Risk Proxy for deprivation by adding 10 years ( JBS2 + 10) CVD risk includes risk of stroke and equals CHD risk x 4/3

ASSIGN ASsessing cardiovascular risk using Scottish Intercollegiate Guidelines Network guidelines to ASSIGN preventative treatment

ASSIGN Results tested on Scottish Heart Health Cohort Extended ( SHHEC) - 6,419 men - 6,618 women aged in 25 local government districts in Scotland between 1984 and 1995 i.e. local

ASSIGN Age Sex Smoking Family History Systolic BP Cholesterol HDL SIMD

ASSIGN New Features Family History SIMD (Scottish Index of Multiple Deprivation)

Family History Parents developed CVD before 60 Siblings developed CVD before 60 Grandparents, aunts, uncles, first cousins developed CVD before 60 (need 2)

SIMD Scottish Index of Multiple Deprivation Relative Indicator of Deprivation based on datazones 1 – 6,505 Based on 37 Indicators across 7 domains to provide weighted score SIMD scores range from 0.54 to 87.60

SIMD Domains Current Income 28% Employment 28% Health 14% Education 14% Geographic Access 9% Crime 5% Housing 2%

SIMD G22 5HD Allander St, Possilpark SIMD 73.4 G62 8PN Allander Road, Milngavie SIMD 9.81 (Range in Scotland 0.54 – 87.60)

ASSIGN Scores Male 50 smoker SBP150 Chol 6, HDL1,FH G22 5HD (Possil) 32% G62 8PN (Milngavie) 22% Fem 60, smoker SBP 140, Chol 6 HDL1,FH G22 5HN (Possil) 49% G62 8PN (Milngavie) 31%

Effect of ASSIGN CVD Risk FRAM 30 ASS30 ASS20 Affluent men 7% 3% 10% Deprived men 10% 9% 24% Affluent women 0% 0% 2% Deprived women 4% 7% 30%

ASSIGN ASSIGN 20 would commit 1 in 3 asymptomatic individuals aged 40 to drug treatment, with its attendant medical and social costs

ASSIGN Being Evaluated by Keep Well i.e. YOU This means we are looking at effect of using ASSIGN as against JBS2 and JBS2+10 How many and which patients move into and out of high risk groups (depending on where we decide “high risk” lies)

ASSIGN This means we are asking that you use all three scores where they are available We know many are missing and that makes evaluation difficult

Previous Guidelines Primary Prevention Cholesterol 30% CHD = 40% CVD BP 15% CHD = 20% CVD Antiplatelet 30% CHD = 40% CVD JBS2 20% CVD SIGN 97 20% CVD

New Guidelines UNIFIED TARGET TREAT at 30 % CVD RISK

NEW PATIENTS Calculate JBS2, JBS and ASSIGN Treat according to ASSIGN 30

TAKE HOME MESSAGES Use 30% CVD risk Record JBS2, JBS and ASSIGN for 1 st appointment 1st appointment ( new cases) use ASSIGN 30